Ajax-Loading

Sojitz Corp. - Ebitda

Sojitz Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Ebitda" stands at 139.40 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Sojitz Corp.'s second quarter result of 40.08 Billion JPY for the item "Ebitda" represents an increase of 67.56 percent compared to it's first quarter result.

Also, Sojitz Corp.'s second quarter result of 40.08 Billion JPY for the item "Ebitda" represents an increase of 30.74 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sojitz Corp.'s second quarter result of 139.40 Billion JPY for the item "Ebitda" represents an increase of 7.25 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -8.26 percent compared to the value the year prior.
The 1 year change in percent is -8.26.
The 3 year change in percent is -51.63.
The 5 year change in percent is 41.99.
The 10 year change in percent is 97.82.

The Serie's long term average value is 119.37 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 16.78 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2016, to it's latest available value, on 09/30/2025, is +139.24%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -59.62%.

Ebitda for Related Companies:

LogoNameMarket Cap (USD)
LogoBerkshire Hathaway Inc - Ebitda1,088,030,244,864.00
LogoBlackstone Group Inc - Ebitda186,696,990,720.00
LogoBlackRock Inc - Ebitda166,346,604,544.00
LogoKKR & Co LP - Ebitda119,832,821,760.00
LogoBioPharma Credit PLC - Ebitda101,856,345,600.00